...
首页> 外文期刊>Frontiers in Pediatrics >An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme
【24h】

An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme

机译:在新生儿镰状细胞筛查计划中对三种传播载体状态结果的三种方式的评估

获取原文
           

摘要

Aim: Sickle cell disease (SCD) is the most frequent monogenic disease worldwide; ~5–7% of the world population carry a hemoglobin disorder trait. In the US, one in every 1,941 newborns has SCD, whereas one in every 3,000 newborns in France is affected - resulting in 385 new cases and 5,883 newly identified carriers per year. The objective of the present study was to evaluate three different ways of providing information to parents at risk of having a child with SCD, with a view to increasing the parental screening rate and decreasing the number of new cases per year in France. Method: In a randomized study, we contacted 300 couples of parents after their child had been identified as a SCD carrier in the French national newborn screening programme: 100 couples received an information letter (the standard procedure in France: arm A), 100 couples received a letter and then a follow-up phone call (arm B), and 100 received a letter and then three follow-up text messages at 5-day intervals (arm C). The primary endpoint was the number of parents in each arm screened in the 120 days after the letter had been sent. In a modified intention-to-treat analysis, the screening rate was 17% in arm A, 35% in arm B, and 30% in arm C. Results: Telephone and text message follow-ups were associated with higher screening rates, compared with no follow-up. After being informed of their child's carrier status, some parents had consulted a healthcare professional but had not been referred for screening (16% in arm A, 19% in arm B, and 13% in arm C). Conclusion: A letter followed by a phone call or three text messages is more effective than a letter alone for informing parents at risk of having a child with SCD. The effective implementation of this follow-up programme probably requires better training of all the healthcare professionals involved.
机译:目的:镰状细胞疾病(SCD)是全球最常见的单一的单一疾病; 〜5-7%的世界人口携带血红蛋白障碍特质。在美国,每1,941名新生儿都有一个SCD,而法国每3,000名新生儿中的一次受影响 - 导致385个新案件和每年新识别的载体。本研究的目的是评估三种不同的方式,以便为父母提供具有SCD的儿童的父母的信息,以提高父母的筛查率并降低法国每年新案件的数量。方法:在一项随机研究中,我们联系了孩子在法国国家新生儿筛查计划中被确定为SCD载体后的300夫妇父母:100夫妇收到了一个信息信(法国标准程序:ARM A),100对夫妻收到一封信,然后收到后续电话(ARM B)和100收到一封信,然后以5天的间隔(ARM C)进行三个后续短信。主要端点是在发送信后120天内筛选的每只手臂中的父母数量。在修改的意图治疗分析中,臂A的筛选率为17%,ARM B中的35%,ARM C中30%。结果:相比,电话和文本消息随访较高的筛选率没有随访。在被告知其孩子的载体地位后,一些父母咨询了医疗保健专业人士,但尚未被提及筛查(16%的ARM A,ARM B中的16%,ARM C中的13%)。结论:一封信,后跟电话或三条短信比单独的一封信更有效,以便向父母提供与SCD的孩子的风险。这种后续计划的有效实施可能需要更好地培训所涉及的所有医疗保健专业人员。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号